{"cursor":"8206","size":15,"audio":[],"currentlang":"en","article":"\n\n{{Infobox company\n| name = MedImmune, LLC logo = | type = Subsidiary of AstraZeneca genre = fate =\n| predecessor = successor = foundation = founder = defunct = location_city =\n| location_country = location = Gaithersburg, Maryland, USA locations =\n| area_served = key_people = industry = Pharmaceutical products =\n| Synagis FluMist production = services = revenue = operating_income =\n| net_income = aum = assets = equity = owner = num_employees = parent =\n| divisions = subsid = homepage = [http://www.medimmune.com/ www.medimmune.com]\n| footnotes = intl =\n}}\n\n'MedImmune, LLC', headquartered in Gaithersburg, Maryland, became a wholly owned\nsubsidiary of AstraZeneca in 2007. Since being acquired, MedImmune has remained\na Maryland-based biotechnology development enterprise. It produces Synagis, a\ndrug for the prevention of respiratory infections in infants, which accounted\nfor US$ 1.06 billion of its US$ 1.2 billion in revenue for 2005, and FluMist, a\nnasal spray influenza vaccine introduced in 2004. MedImmune acquired FluMist\nwhen it purchased Aviron in 2002 for US$ 1.5 billion. FluMist sales totaled US$\n104 million in 2008, US$ 54.8 million in 2007, and US$ 36.4 million in 2006. {{cite news\n | url=http://www.washingtonpost.com/wp-\n | dyn/content/article/2009/06/01/AR2009060101608.html title=MedImmune Wins Key\n | Contract To Develop Swine Flu Vaccine author=Michael S. Rosenwald date=June\n | 2, 2009 accessdate=October 23, 2009 work=The Washington Post\n}}\n\nFluMist was approved for children two years of age and older in 2007, but\ninitially was approved only for healthy people ages 5 to 49, a significant\nlimitation because it eliminated a significant marketâthe millions of young\nchildren who find injections objectionable. Sales of FluMist fell short of\nanalysts' expectations for the first two years the drug was sold. FluMist was\ninitially sold in a frozen form, which was difficult for doctors to store.\n* [http://www.medimmune.com Medimmune Company Site]\n* [http://www.flumist.com Flumist nasal flu vaccine - Official website]\n* Bishop, Tricia. \"MedImmune loss in '05 quadruples shortfall from '04\"\n  Baltimore Sun. 3 February 2006.\n* Rosenwald, Michael S. \"[http://www.washingtonpost.com/wp-\n  dyn/content/article/2006/02/02/AR2006020202320.html Sales of MedImmune's Flu\n  Vaccine Drop Sharply]\" Washington Post. 3 February 2006.\n\nMedImmune conducted successful clinical trials for a new generation of FluMist\nneedle-free vaccine, called CAIV-T, which was approved by the U.S. Food and Drug\nAdministration (FDA) in 2007, and is now the form offered on the market.\n","linknr":302,"url":"MedImmune","recorded":1376418689,"links":["/w/index.php?title=MedImmune&action=edit","/w/index.php?title=MedImmune&action=edit","//bits.wikimedia.org/favicon/wikipedia.ico","/w/opensearch_desc.php","//en.wikipedia.org/w/api.php?action=rsd","//creativecommons.org/licenses/by-sa/3.0/","/w/index.php?title=Special:RecentChanges&feed=atom","http://en.wikipedia.org/wiki/MedImmune","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cteahouse%7Cext.rtlcite%2Cwikihiero%7Cext.uls.nojs%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmw.PopUpMediaTransform%7Cskins.vector&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.visualEditor.viewPageTarget.noscript&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=startup&only=scripts&skin=vector&*","//bits.wikimedia.org/geoiplookup","//meta.wikimedia.org","#mw-navigation","#p-search","//upload.wikimedia.org/wikipedia/en/f/f4/Ambox_content.png","/wiki/Wikipedia:NOT#SOAPBOX","//en.wikipedia.org/w/index.php?title=MedImmune&action=edit","/wiki/Wikipedia:Neutral_point_of_view","/wiki/Wikipedia:EL","/wiki/File:MedImmune_logo.gif","//upload.wikimedia.org/wikipedia/en/thumb/c/c0/MedImmune_logo.gif/250px-MedImmune_logo.gif","/wiki/Types_of_business_entity","/wiki/Subsidiary","/wiki/AstraZeneca","/wiki/Pharmaceutical_company","/wiki/Gaithersburg,_Maryland","/wiki/Maryland","/wiki/USA","/wiki/Palivizumab","/wiki/FluMist","http://www.medimmune.com/","/wiki/Gaithersburg,_Maryland","/wiki/Maryland","/wiki/AstraZeneca","/wiki/Biotechnology","/wiki/Palivizumab","/wiki/United_States_dollar","/wiki/United_States_dollar","/wiki/FluMist","/wiki/Nasal_spray","/wiki/Influenza_vaccine","/wiki/United_States_dollar","/wiki/United_States_dollar","/wiki/United_States_dollar","/wiki/United_States_dollar","#cite_note-WashPost-June09-1","#cite_note-medref-2","/wiki/Clinical_trials","/wiki/Food_and_Drug_Administration_(United_States)","#History","#2012-2013_Flu_Season","#FluMist_Distribution","#Target_Age_Groups","#Coverage","#See_also","#Sources_and_notes","#External_links","/w/index.php?title=MedImmune&action=edit&section=1","/w/index.php?title=MedImmune&veaction=edit&section=1","#cite_note-medref-2","/wiki/AstraZeneca","/wiki/United_States_dollar","/wiki/United_States_dollar","#cite_note-medref-2","/wiki/United_States_dollar","#cite_note-3","/wiki/Cambridge_Antibody_Technology","#cite_note-4","/wiki/National_Institutes_of_Health","/wiki/H5N1_clinical_trials","/wiki/Influenza_vaccine","#cite_note-5","/wiki/Pandemic_H1N1/09_virus","/wiki/2009_flu_pandemic","#cite_note-MedImmune-6","/wiki/Department_of_Health_and_Human_Services","#cite_note-WashPost-June09-1","#cite_note-7","#cite_note-MedImmune-6","/w/index.php?title=MedImmune&action=edit&section=2","/w/index.php?title=MedImmune&veaction=edit&section=2","/w/index.php?title=MedImmune&action=edit&section=3","/w/index.php?title=MedImmune&veaction=edit&section=3","#cite_note-vaccinenewsdaily.com-8","/w/index.php?title=MedImmune&action=edit&section=4","/w/index.php?title=MedImmune&veaction=edit&section=4","/wiki/Food_and_Drug_Administration","#cite_note-vaccinenewsdaily.com-8","/wiki/Centers_for_Disease_Control_and_Prevention","#cite_note-vaccinenewsdaily.com-8","/w/index.php?title=MedImmune&action=edit&section=5","/w/index.php?title=MedImmune&veaction=edit&section=5","/wiki/Vaccines_for_Children_Program","#cite_note-vaccinenewsdaily.com-8","/w/index.php?title=MedImmune&action=edit&section=6","/w/index.php?title=MedImmune&veaction=edit&section=6","/wiki/MedImmune,_Inc._v._Genentech,_Inc.","/w/index.php?title=MedImmune&action=edit&section=7","/w/index.php?title=MedImmune&veaction=edit&section=7","#cite_ref-WashPost-June09_1-0","#cite_ref-WashPost-June09_1-1","http://www.washingtonpost.com/wp-dyn/content/article/2009/06/01/AR2009060101608.html","#cite_ref-medref_2-0","#cite_ref-medref_2-1","#cite_ref-medref_2-2","http://www.medimmune.com","http://www.flumist.com","http://www.washingtonpost.com/wp-dyn/content/article/2006/02/02/AR2006020202320.html","#cite_ref-3","http://money.cnn.com/2007/04/23/news/companies/astrazeneca/index.htm","#cite_ref-4","http://www.astrazeneca.com/media/latest-press-releases/2007/5364?itemId=3891554","#cite_ref-5","http://phx.corporate-ir.net/phoenix.zhtml?c=83037&p=irol-newsArticle_Print&ID=872852&highlight=","#cite_ref-MedImmune_6-0","#cite_ref-MedImmune_6-1","http://www.medimmune.com/h1n1.aspx","#cite_ref-7","http://www.bizjournals.com/washington/stories/2009/07/13/daily21.html","#cite_ref-vaccinenewsdaily.com_8-0","#cite_ref-vaccinenewsdaily.com_8-1","#cite_ref-vaccinenewsdaily.com_8-2","#cite_ref-vaccinenewsdaily.com_8-3","http://vaccinenewsdaily.com/vaccine_development/321033-medimmune-begins-flumist-distribution/","/w/index.php?title=MedImmune&action=edit&section=8","/w/index.php?title=MedImmune&veaction=edit&section=8","http://www.flumist.com/","/wiki/Template:AstraZeneca","/wiki/Template_talk:AstraZeneca","//en.wikipedia.org/w/index.php?title=Template:AstraZeneca&action=edit","/wiki/AstraZeneca","/wiki/Anastrozole","/wiki/Atenolol","/wiki/Brompheniramine","/wiki/Budesonide","/wiki/Disufenton_sodium","/wiki/Esomeprazole","/wiki/Live_attenuated_influenza_vaccine","/wiki/Gefitinib","/wiki/Goserelin","/wiki/Isosorbide_mononitrate","/wiki/Motavizumab","/wiki/Omeprazole","/wiki/Palivizumab","/wiki/Propofol","/wiki/Rosuvastatin","/wiki/Tamoxifen","/wiki/Ticagrelor","/wiki/Vandetanib","/wiki/Ximelagatran","/wiki/Zolmitriptan","/wiki/Astra_AB","/wiki/Cambridge_Antibody_Technology","/wiki/Zeneca","/wiki/Tom_McKillop","/wiki/Louis_Schweitzer_(CEO)","//upload.wikimedia.org/wikipedia/en/thumb/4/48/Folder_Hexagonal_Icon.svg/16px-Folder_Hexagonal_Icon.svg.png","/wiki/Category:AstraZeneca","/wiki/Template:Pharmaceutical_and_biotechnology_industry_in_the_United_Kingdom","/wiki/Template_talk:Pharmaceutical_and_biotechnology_industry_in_the_United_Kingdom","//en.wikipedia.org/w/index.php?title=Template:Pharmaceutical_and_biotechnology_industry_in_the_United_Kingdom&action=edit","/wiki/United_Kingdom","//upload.wikimedia.org/wikipedia/en/thumb/a/ae/Flag_of_the_United_Kingdom.svg/23px-Flag_of_the_United_Kingdom.svg.png","/wiki/Pharmaceutical_industry_in_the_United_Kingdom","/wiki/Manufacturing_in_the_United_Kingdom","/wiki/Economy_of_the_United_Kingdom","/wiki/List_of_pharmaceutical_manufacturers_in_the_United_Kingdom","/wiki/AAH_Pharmaceuticals","/wiki/Alliance_Boots","/wiki/Astex","/wiki/AstraZeneca","/wiki/BTG","/wiki/Cyclacel","/wiki/Dechra_Pharmaceuticals","/wiki/GE_Healthcare","/wiki/Genus_plc","/wiki/GlaxoSmithKline","/wiki/Hikma_Pharmaceuticals","/wiki/Intercytex","/wiki/MacFarlan_Smith","/wiki/Norbrook_Group","/wiki/Oxford_BioMedica","/wiki/Pfizer_UK","/wiki/Phytopharm","/wiki/Proximagen","/wiki/Renovo_plc","/wiki/Shire_plc","/wiki/Silence_Therapeutics","/wiki/TBS_GB","/wiki/Unipath","/wiki/Vectura_Group","/wiki/Vernalis_plc","/wiki/ViiV_Healthcare","/wiki/Allen_%26_Hanburys","/wiki/Amersham_plc","/wiki/Beecham_Group","/wiki/Cambridge_Antibody_Technology","/wiki/Celltech","/wiki/Chiroscience","/wiki/Distillers_Company","/wiki/Fisons","/wiki/Glaxo_Wellcome","/wiki/Reliant_Pharmaceuticals","/wiki/Zeneca","/wiki/Commission_on_Human_Medicines","/wiki/Department_of_Health_(United_Kingdom)","/wiki/European_Directorate_for_the_Quality_of_Medicines","/wiki/European_Medicines_Agency","/wiki/Medicines_and_Healthcare_products_Regulatory_Agency","/wiki/National_Collaborating_Centre_for_Mental_Health","/wiki/National_Patient_Safety_Agency","/wiki/Pharmaceutical_Society_of_Northern_Ireland","/wiki/General_Pharmaceutical_Council","/wiki/Scottish_Medicines_Consortium","/wiki/Veterinary_Medicines_Directorate","/wiki/Association_of_the_British_Pharmaceutical_Industry","/wiki/Chemical_Industries_Association","/wiki/European_Federation_of_Biotechnology","/wiki/European_Federation_of_Pharmaceutical_Industries_and_Associations","/wiki/Faculty_of_Pharmaceutical_Medicine","/wiki/Pharmacists%27_Defence_Association","/wiki/Royal_Pharmaceutical_Society_of_Great_Britain","/wiki/Worshipful_Society_of_Apothecaries","/wiki/Bandolier_(journal)","/wiki/Bad_Pharma","/wiki/British_National_Formulary","/wiki/British_National_Formulary_for_Children","/wiki/Monthly_Index_of_Medical_Specialities","/wiki/British_Approved_Name","/wiki/British_Pharmacopoeia","/wiki/DrugScope","/wiki/European_and_Developing_Countries_Clinical_Trials_Partnership","/wiki/European_Pharmacopoeia","/wiki/List_of_pharmaceutical_companies","/wiki/Pharmaceutical_Services_Negotiating_Committee","//upload.wikimedia.org/wikipedia/en/thumb/4/48/Folder_Hexagonal_Icon.svg/16px-Folder_Hexagonal_Icon.svg.png","/wiki/Category:Pharmaceutical_industry_in_the_United_Kingdom","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","http://en.wikipedia.org/w/index.php?title=MedImmune&oldid=544069147","/wiki/Help:Category","/wiki/Category:Companies_based_in_Gaithersburg,_Maryland","/wiki/Category:Biotechnology_companies_of_the_United_States","/wiki/Category:Vaccine_producers","/wiki/Category:AstraZeneca","/wiki/Category:Companies_established_in_1988","/wiki/Category:Gaithersburg,_Maryland","/wiki/Category:Articles_with_a_promotional_tone_from_October_2009","/wiki/Category:All_articles_with_a_promotional_tone","/w/index.php?title=Special:UserLogin&returnto=MedImmune&type=signup","/w/index.php?title=Special:UserLogin&returnto=MedImmune","/wiki/MedImmune","/wiki/Talk:MedImmune","#","/wiki/MedImmune","/w/index.php?title=MedImmune&action=edit","/w/index.php?title=MedImmune&veaction=edit","/w/index.php?title=MedImmune&action=history","#","/w/index.php","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","/wiki/Main_Page","/wiki/Main_Page","/wiki/Portal:Contents","/wiki/Portal:Featured_content","/wiki/Portal:Current_events","/wiki/Special:Random","https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en","/wiki/Help:Contents","/wiki/Wikipedia:About","/wiki/Wikipedia:Community_portal","/wiki/Special:RecentChanges","//en.wikipedia.org/wiki/Wikipedia:Contact_us","/wiki/Special:WhatLinksHere/MedImmune","/wiki/Special:RecentChangesLinked/MedImmune","/wiki/Wikipedia:File_Upload_Wizard","/wiki/Special:SpecialPages","/w/index.php?title=MedImmune&oldid=544069147","/w/index.php?title=MedImmune&action=info","//www.wikidata.org/wiki/Q1335294","/w/index.php?title=Special:Cite&page=MedImmune&id=544069147","/w/index.php?title=Special:Book&bookcmd=book_creator&referer=MedImmune","/w/index.php?title=Special:Book&bookcmd=render_article&arttitle=MedImmune&oldid=544069147&writer=rl","/w/index.php?title=MedImmune&printable=yes","//de.wikipedia.org/wiki/MedImmune","#","//www.wikidata.org/wiki/Q1335294#sitelinks-wikipedia","//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License","//creativecommons.org/licenses/by-sa/3.0/","//wikimediafoundation.org/wiki/Terms_of_Use","//wikimediafoundation.org/wiki/Privacy_policy","//www.wikimediafoundation.org/","//wikimediafoundation.org/wiki/Privacy_policy","/wiki/Wikipedia:About","/wiki/Wikipedia:General_disclaimer","//en.wikipedia.org/wiki/Wikipedia:Contact_us","//en.m.wikipedia.org/wiki/MedImmune","//wikimediafoundation.org/","//bits.wikimedia.org/images/wikimedia-button.png","//www.mediawiki.org/","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=scripts&skin=vector&*"],"instances":["united_states"],"pdf":[],"categories":["Companies based in Gaithersburg, Maryland","Biotechnology companies of the United States","Vaccine producers","AstraZeneca","Companies established in 1988","Gaithersburg, Maryland"],"headings":["History","2012-2013 Flu Season","See also","Sources and notes","External links"],"image":["//upload.wikimedia.org/wikipedia/en/f/f4/Ambox_content.png","//upload.wikimedia.org/wikipedia/en/thumb/c/c0/MedImmune_logo.gif/250px-MedImmune_logo.gif","//upload.wikimedia.org/wikipedia/en/thumb/4/48/Folder_Hexagonal_Icon.svg/16px-Folder_Hexagonal_Icon.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/a/ae/Flag_of_the_United_Kingdom.svg/23px-Flag_of_the_United_Kingdom.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/4/48/Folder_Hexagonal_Icon.svg/16px-Folder_Hexagonal_Icon.svg.png","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","//bits.wikimedia.org/images/wikimedia-button.png","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png"],"tags":[["food_and_drug_administration","united_states"]],"members":["food_and_drug_administration"],"related":["Subsidiary","AstraZeneca","Gaithersburg,_Maryland","Maryland","USA","Pharmaceutical_company","Palivizumab","FluMist","Gaithersburg,_Maryland","Maryland","AstraZeneca","Biotechnology","Palivizumab","United_States_dollar","United_States_dollar","FluMist","Nasal_spray","Influenza_vaccine","United_States_dollar","United_States_dollar","United_States_dollar","United_States_dollar","Clinical_trials","Food_and_Drug_Administration_(United_States)","AstraZeneca","United_States_dollar","United_States_dollar","United_States_dollar","Cambridge_Antibody_Technology","National_Institutes_of_Health","H5N1_clinical_trials","Influenza_vaccine","Pandemic_H1N1/09_virus","2009_flu_pandemic","Department_of_Health_and_Human_Services","Food_and_Drug_Administration","Centers_for_Disease_Control_and_Prevention","Vaccines_for_Children_Program","MedImmune,_Inc._v._Genentech,_Inc."]}